Product Name:
Pazopanib Hcl
Latin Name:
Unii-33Y9anm545
CAS NO:
635702-64-6
MF:
C21H23N7O2S.ClH
MW:
473.987
EINECS NO; 619-728-0
Pazopanib hydrochloride is an oral angiogenesis inhibitor targeting VEGFR and PDGFR. Pazopanib hydrochloride is a multi-targeted tyrosine kinase inhibitor that inhibits angiogenesis for the treatment of advanced renal cell carcinoma (RCC).
Capecitabine | Everolimus | Afatinib | Vandetanib | Gefitinib |
Temozolomid | Rapamycin | Axitinib | Sorafenib tosylate | Cediranib |
Cabozantinib | Selumetinib | Crizotinib | Sunitinib malate | Erlotinib |
Crizotinib | Lapatinib | Debrafenib | Cabazitaxel | Ponatinib |
1. Customs clearance